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Background: Myogenesis is initiated by myoblast differentiation and fusion to form myotubes and muscle fibres. A
population of myoblasts, known as satellite cells, is responsible for post-natal growth of muscle and for its regeneration.
This differentiation requires many changes in cell behaviour and its surrounding environment. These modifications are
tightly regulated over time and can be characterized through the study of changes in gene expression associated with
this process. During the initial myogenesis steps, using the myoblast cell line C2C12 as a model, Janot et al. (2009)
showed significant variations in expression for genes involved in pathways of glycolipid synthesis. In this study we
used murine satellite cells (MSC) and their ability to differentiate into myotubes or early fat storage cells to select
glycosylation related genes whose variation of expression is myogenesis specific.
Results: The comparison of variant genes in both MSC differentiation pathways identified 67 genes associated
with myogenesis. Comparison with data obtained for C2C12 revealed that only 14 genes had similar expression
profiles in both cell types and that 17 genes were specifically regulated in MSC. Results were validated statistically
by without a priori clustering. Classification according to protein function encoded by these 31 genes showed that
the main regulated cellular processes during this differentiation were (i) remodeling of the extracellular matrix,
particularly, sulfated structures, (ii) down-regulation of O-mannosyl glycan biosynthesis, and (iii) an increase in
adhesion protein expression. A functional study was performed on Itga11 and Chst5 encoding two highly up-regulated
proteins. The inactivation of Chst5 by specific shRNA delayed the fusion of MSC. By contrast, the inactivation of Itga11
by specific shRNA dramatically decreased the fusion ability of MSC. This result was confirmed by neutralization of Itga11
product by specific antibodies.
Conclusions: Our screening method detected 31 genes specific for myogenic differentiation out of the 383 genes
studied. According to their function, interaction networks of the products of these selected genes converged to cell
fusion. Functional studies on Itga11 and Chst5 demonstrated the robustness of this screening.
Keywords: Glycosylation related genes, Satellite cells, C2C12, Myogenesis, Adhesion, Integrins, ITGA11, Early
adipogenesis, Chst5Background
Satellite cells are adult stem cells specific to skeletal
muscle. They are located between the basal lamina and
striated muscle cells in muscle tissue, and their princi-
pal roles are post-natal growth, maintenance and the
regeneration of skeletal muscle [1-3]. Satellite cells may
undergo asymmetric division for their renewal and produce
daughter cells that enter into myogenic differentiation [4].
Satellite cells are multipotent and can differentiate into* Correspondence: jean-michel.petit@unilim.fr
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unless otherwise stated.early fat storage cells or osteoblasts under different
environmental conditions [5,6]. Gene expression com-
parison allows for the characterization of the genes
specific to each pathway.
Myogenesis is composed of three steps, (i) alignment
of cells, (ii) fusion of cells in myotubes, and (iii) matur-
ation of myotubes. These three steps are regulated by
various transcription factors such as the myogenic
regulation factors (Mrfs) [4,7-11]. The study of gene
expression variation during cell differentiation is fluently
used to determine the genes with the most interest [12]. It
is also well established that interactions between theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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interactions play a major role in myogenesis [13]. Such
regulations and interactions are different from those
involved in early-adipogenesis. Therefore, both path-
ways require tightly regulated recognition systems. One
of the better systems to enhance specificity of recogni-
tion is glycans and adhesion proteins.
Glycosylation is a process that leads to the formation
of a great diversity of glycan structures. These struc-
tures are specifically involved in response to the cell
environment during developmental stages, and cell fate
[14]. We selected genes whose products are involved in
glycan synthesis (e.g. nucleotide sugar transporters and
glycosyltransferases) as well as genes encoding protein,
which recognize glycan structure such as lectins (e.g.
selectin), adhesion molecule family (e.g. melanoma cell
adhesion molecule) and other adhesion proteins (e.g.
integrin family). These genes are called Glycosylation
Related Genes (GRG). Janot et al. demonstrated the
change in expression for some of these genes during
early myogenic differentiation of the murine cell line
C2C12 [15]. Using this cell model, they suggested that
myoblast fusion may require glycosphingolipid rear-
rangements and/or terminal modifications on glycolipids
and glycoproteins (such as fucosylation and sialylation).
Among glycoproteins, the adhesion proteins must
play a crucial role in cell migration and adhesion; one
of the most important families is composed of the
integrins [16-18].
Integrins are plasma membrane heterodimers that me-
diate both cell-cell and cell-extracellular matrix interac-
tions [19]. Integrin subfamilies are classified on the basis
of the association of a common β subunit with distinct α
subunits to form unique heterodimers. The integrins
ITGA4 and ITGB1 have already been described for their
myogenic role. They form the VLA-4 complex, an essen-
tial adhesion complex interacting with VCAM1 to influ-
ence cell alignment and/or cell fusion [20].
In this study, we compared the expression of 383
genes during the differentiation of murine satellite
cells (MSC) into myotubes or early fat storage cells.
Comparison of gene expressions in both differen-
tiation pathways and previous data on C2C12 [15]
revealed that only 31 genes were mainly involved in
myogenesis. Fourteen of them have the same variation pro-
file during C2C12 and MSC myogenesis. The remaining
seventeen showed a variation only during MSC myo-
genesis while they were significantly expressed without
changes during C2C12 differentiation; e.g. the gene
encoding the integrin alpha 11 subunit (Itga11). The use
of shRNA or neutralizing antibodies against this integ-
rin subunit decreased cell fusion by at least 50%. Thus
Itga11 is critically involved in myotube formation using
MSC as a model.Results
MSC differentiation and selection of GRG specific to
myogenesis
To identify genes which displayed an expression vari-
ation in myogenesis with MSC as progenitor cells, we
profiled and compared gene expression during myo-
genesis or early-adipogenesis. MSC seeded on Matrigel®
were differentiated by reduction of serum for 72 hours or
trans-differentiated in the presence of ambient 50 mM
glucose for 168 hours. The time points were chosen to
obtain a percentage of myotubes in myogenic differen-
tiation similar to the percentage of early fat storage cells
obtained in trans-differentiation. The differentiation state
was confirmed by (i) staining of nuclei in myotubes to
quantify the percentage of fusion or to follow fat storage
accumulation to determine the trans-differentiation state
(Additional file 1); and (ii) measurement of MyoG, MyoD1,
Myf5 and Myf6 myogenic markers and Dlk1 and Ppara
markers of the early adipogenic step (Figure 1). In myo-
genic differentiation conditions, MyoG expression dra-
matically increased (70 fold) during the first 24 hours
before reaching a plateau (Figure 1) whereas in trans-
differentiated MSC it did not exceed 4 fold. A contrast-
ing variation of Myf5 expression was observed, with
expression increasing during myogenesis only. Surpris-
ingly, Myf6 and MyoD1 transcription were similar in both
pathways. This similarity between trans-differentiation
and myogenesis could be explained by the presence of
ambient glucose which tends to increase myogenic
differentiation in cells already engaged in this process [21].
As expected for the adipogenic markers Dlk1 and Ppara,
expression increased notably during trans-differentiation
whereas no significant variations were observed during
myogenesis (Figure 1B). These results showed the
precise control of MSC myogenic differentiation into
myotubes or trans-differentiation into early fat storage
cells, respectively.
Thus, we can follow and compare the expression of
glycogenes and genes encoding adhesion proteins dur-
ing MSC differentiation in both pathways. Only GRG
with a change in mRNA expression of at least two folds
was retained for each differentiation pathway. Using
this comparative approach we identified 112 genes with
a significant variation. Among them, only 67 genes had a
variation specific for MSC myogenesis (Additional file 2).
The remaining 45, which also varied during early adi-
pogenesis, were discarded. Then, we compared our
results with the myoblastic cell line C2C12 [15].
GRG is specifically involved in myogenesis
Since C2C12 cultures were seeded on plates without
Matrigel® in the previous study [15], we controlled that
culture on Matrigel® did not improve the differenti-
ation potential of these cells. The comparison between
Figure 1 Expression of myogenic and early step adipogenic markers. A. The expression of four myogenic regulation factors (MyoG (circles),
MyoD1 (squares), Myf5 (diamonds), Myf6 (triangles)) during satellite cell differentiation in myotubes (black) and satellite cell trans-differentiation in
early fat storage cells (white); standard error was calculated from three independent experimentations. B. Relative expression of early adipogenic
markers Ppara and Dlk1, in myotubes (black) and early fat storage cells (white) in comparison with expression in undifferentiated satellite cells,
triplicates were used to calculate the standard error.
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out it revealed no significant difference in differentiation
induction, as recently reported [22]. We also demon-
strated that no difference appeared in the fusion index
and Myogenin expression (Figure 2). The expression of
Itgb8 as a reference, during myogenic differentiation
of C2C12 seeded on plates coated with Matrigel® or
not, showed no difference between the two culture
conditions (Figure 2).
The comparison of 67 specifically up or down regu-
lated genes during MSC myogenesis to the resultsFigure 2 Myogenic differentiation of C2C12 with or without Matrigel®
(square) or not (triangle) with Matrigel®. The fusion index was measured ev
symbols), vertical bars correspond to standard errors (n = 3). Relative mRNA
measured every 24 hours by qRT-PCR using Taqman probes (white symbolobtained by Janot et al. [15] led to the identification of
two subgroups. The first included 17 genes without
expression variation throughout C2C12 differentiation
whereas their expression varied during MSC differen-
tiation (group B, Table 1). In the second subgroup, 50
genes were identified whose expression varied in both
cell types (Figure 3). Among the latter, only 14 had
similar variation profiles during C2C12 and MSC
myogenesis (group A, Table 1). Therefore, 31 genes
seemed to be essential for myogenic differentiation
(Figure 3) and were retained for further studies.. The C2C12 cells were seeded at 5x103 cells/cm2 on plates coated
ery 24 hours after differentiation induction by serum starvation (black
quantities of MyoG (solid line) or Itgb8 (dotted line) were also
s).
Table 1 List of 31 selected genes whose expression varied during myogenesis only
mRNA Relative quantity according to differentiation time
Gene symbol Expression pattern 0 h 12 h 24 h 48 h 72 h
A
Art1 Up-regulated 1 1.759 1.205 13.63 39.324
Chst5 Up-regulated 1 22.203 53.793 18.009 8.642
Clec2d Up-regulated 1 1.463 2.017 1.222 2.065
Galntl1 Up-regulated 1 1.455 1.635 0.87 2.689
Gcnt2 Up-regulated 1 0.84 2,000 1.539 1.324
Icam2 Up-regulated 1 2.037 3.854 2.465 5.674
Itga6 Up-regulated 1 3.773 2.976 2.037 n.d.
Lgals7 Up-regulated 1 0.468 2.174 2.332 4.369
Chst10 Down-regulated 1 0.641 0.572 0.455 0.726
Chst8 Down-regulated 1 0.204 0.18 0.087 0.069
Clec4d Down-regulated 1 1.161 0.322 0.475 0.913
Clgn Down-regulated 1 0.012 0.067 0.094 0.549
Fut10 Down-regulated 1 0.372 0.366 0.444 0.566
Itgb7 Down-regulated 1 0.287 0.285 0.165 0.435
B
B4galt1 Up-regulated 1 1.09 1.427 1.613 2.585
Cd248 Up-regulated 1 2.298 3.064 5.072 10.464
Chst12 Up-regulated 1 0.894 1.238 1.498 2.177
Cmah Up-regulated 1 1.99 2.451 2.611 2.394
Fcna Up-regulated 1 5.418 2.369 2.143 2.827
Has1 Up-regulated 1 4.283 0.015 4.635 7.508
Has2 Up-regulated 1 0.002 3.583 0.001 2.982
Hpse Up-regulated 1 2.174 1.227 1.17 3.223
Itga11 Up-regulated 1 20.773 40.039 100.962 316.34
Itga5 Up-regulated 1 1.986 3.011 2.995 n.d.
Itgb8 Up-regulated 1 1.538 2.21 4.789 6.166
Klra2 Up-regulated 1 1.73 1.279 4.221 11.168
Mcam Up-regulated 1 0.967 1.687 1.894 2.126
Pigc Up-regulated 1 1.08 1.521 1.714 2.475
Renbp Up-regulated 1 1.926 2.156 2.155 2.21
Fuk Down-regulated 1 0.428 0.636 0.559 0.573
Pmm1 Down-regulated 1 0.499 0.857 1.042 1.013
n.d.: “not determined”.
A. Group of genes with the same variation during myogenic differentiation of C2C12 and satellite cells. B. Group of genes with variation during myogenic
differentiation of satellite cells and no variation during C2C12 differentiation. Numbers in bold were considered as significant variations represented by relative
mRNA quantities less than 0.5 or up to 2. n.d.: not determined.
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We performed clustering analysis in order to group
genes with similar expression patterns. An unsuper-
vised hierarchical clustering algorithm was used to
study 67 genes. This approach, described in Materials
and Methods, relies on the time course comparison of
differential expression of each gene when C2C12 and
MSC strains are analyzed.
The resulting tree was split into eight groups (some
details of the subdivisions over the last group (group 8)are given (6 sub-clusters can be identified in this group))
(Figure 4A). 26 genes (from group A or B) fall into the 5
main groups (3, 5, 7, 8(4), 8(6)) (including at least seven
genes). 12 of the fourteen genes of group A are split into
clusters 3, 5, 7 and 8(6) (Figure 4A). In cluster 3, gene
expression increased early in differentiation (a clear up-
regulation) for C2C12 and only at 48 hours for MSC
(Figure 4C). Cluster 5 contains 6 genes from group A
with similar expression profiles in both conditions: these
genes were clearly down-regulated (Figure 4D). In cluster
Figure 3 Determination of myogenesis specific genes. Comparison between 93 genes significantly regulated in early adipogenic
differentiation (pink arrows) and 112 in myogenic differentiation (purple arrows) of Mouse Satellite Cells (MSC) revealed 67 genes specifically
regulated during myogenesis. Among them, 17 genes varied only in MSC and 14 were regulated similarly in C2C12 cells (bold red characters).
They represent the 31 genes of interest in this study. Dotted arrows correspond to genes discarded during the screening.
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ation was higher in MSC than in C2C12 (Figure 4G). This
cluster also includes 4 genes from group B (Figure 4B).
Group 8(4) also contains 7 genes from group B which
had a significant variation in expression only in MSC
(Figure 4E). The remaining group B genes are split
between clusters 5 (2 genes), 7 (1 gene, Figure 4F) and
3 minor groups (1, 6 and 8(1)). We observed that 26 of
the 31 genes selected were gathered “without a priori”.
It demonstrates the confidence we can have in our
selection method.
Myogenesis requires the presence of adhesion proteins
and the sulfation of keratans
As shown in Table 1, we observed the highest changes in
expression for Chst5, Itga11 genes which were the mostup-regulated (54 and 316 fold, respectively) and Itgb7
which was down-regulated (0.16 fold). To understand
what cell processes could be affected by these expression
variations, we classified the 31 genes according to their
function [23-51] (Table 2). We showed that a large part
of these genes encoded adhesion proteins (around 30%),
and only one of them was down-regulated. For the
remaining 19 genes, 4 genes are involved in sulfation
with Chst5 which specifically sulfates the keratans. The
7 down-regulated genes were unrelated to myogenesis
(e.g.: the Clgn product is involved in spermatogenesis
[48]).We observed a difference with the study of Janot
et al. [15] for genes involved in lacto/neolacto series
biosynthesis. Indeed, we found none of the seven genes
previously described. They were discarded because they
varied in both myogenic and early adipogenic pathways.
Figure 4 Clustering analysis of variant genes during myogenesis. Expression profiles of the 67 genes whose transcript levels changed
significantly during myogenesis of mouse satellite cells were used. The resulting tree of hierarchical clustering (see Methods) was split into eight
groups (1 to 8). Group 8 included 28 genes and was split again into six smaller groups (1 to 6) to obtain more homogenous groups. A. Number
of genes in clusters and number of genes found in group A and group B as defined in Table 1. Mean expression profiles for C2C12 (pink) and
MSC (red) of clusters 3, 5, 7 8(4) and 8(6) are shown in C, D, E, F and G. B. Expression map of the five major clusters (boxed in red): 3, 5, 7, 8(4)
and 8(6). C-G. Mean expression profiles obtained for C2C12 (pink) and MSC (red): y-axis represents the standard log2 of expression levels (RQ for
relative quantity). Error bars indicate standard deviation of average expression.
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We observed an increase of ITGA11 in MSC during
myogenic differentiation (Figure 5). These results corre-
lated well to previously observed mRNA levels (Table 1).
Gene repression using shRNA against Itga11 and Itga4
(as a control due to its well-known implication in fusion[52]) was performed on MSC 24 hours before induction
of myogenic differentiation and repression was verified
by RT-PCR (Figure 5A). The amount of ITGA11 was
dramatically reduced in treated MSC although it slightly
increased during differentiation (Figure 5B). A negative
plasmid containing shRNA without any target in the
Table 2 Classification of the 31 selected genes
Gene symbol Expression pattern Function Family
Art1 Up-regulated ADP-ribosylation
Adhesion familly
Cd248 Up-regulated Potential angiogenesis role
Clec2d Up-regulated Osteogenesis inhibitor
Icam2 Up-regulated Cell-cell interaction
Itga5 Up-regulated Matrix remodeling
Itga6 Up-regulated Laminin receptor
Itga11 Up-regulated Collagen receptor
Itgb8 Up-regulated Fibronectin receptor
Klra2 Up-regulated Myosin heavy chain receptor
Lgals7 Up-regulated Cell-cell and cell-EMC interaction
Mcam Up-regulated Cellular adhesion
Itgb7 Down-regulated Lymphocyte homing and retention
B4galt1 Up-regulated Keratan sulfate biosynthesis
Glycanic synthesis/extension
Chst12 Up-regulated Dermatan sulfate biosynthesis
Cmah Up-regulated CMP-N-acetylneuraminic acid hydroxylase
Chst5 Up-regulated Keratan sulfate biosynthesis
Galntl1 Up-regulated O-Glycan core biosynthesis
Gcnt2 Up-regulated O-Glycan core biosynthesis
Has1 Up-regulated Hyaluranane synthase
Has2 Up-regulated Hyaluranane synthase
Hpse Up-regulated Heparanase
Renbp Up-regulated Epimerase
Pigc Up-regulated GPI anchor biosynthesis
Chst8 Down-regulated N-Glycan sulfation
Chst10 Down-regulated O-Glycan sulfation
Pmm1 Down-regulated Phospho-manno mutase
Clec4d Down-regulated Endocytic receptor
Other functions
Clgn Down-regulated Potential spermatogenesis role
Fcna Up-regulated Ficollin
Fut10 Down-regulated Chitobiose fucosylation
Fuk Down-regulated Fucose recycling
The selected 31 genes (Table 1) were classified according to the function of their products.
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regulation of Itga11 before differentiation (Figure 5A) that
did not affect the fusion ability of the cells (Figure 6).
shRNA transfected cells (against Itga11 or Itga4) showed a
large decrease mRNA level in MSC (Figure 5A). This
resulted in a low number of myotubes in treated culture
after 72 hours of myogenic differentiation (Figure 6). The
fusion index obtained for untreated MSC cells or cells
treated with the negative control shRNA did not display a
significant difference (Figure 7). A significant inhibition of
MSC fusion occurred and the fusion index only reached
2.5% for shRNA treatment after 72 hour differentiation
(Figure 7).Itga11 antibodies inhibited the cell fusion
Regarding the effect of Itga11 down-regulation, we pro-
ceeded to study the neutralization of ITGA11 during
differentiation. Treatments were performed on MSC
cultures with antibodies against ITGA11 or ITGA4 (as
control). After 3 days, the fusion index was significantly
reduced for both treatments (Figure 8). At 72 hours, the
fusion indexes of treated cells were reduced by approxi-
mately 65% in both cases. In MSC cultures containing
both antibodies, the fusion index was decreased by 90%
after 72 hour differentiation (Figure 8). This result indi-
cated a direct involvement of ITGA11 in the MSC fusion
and 2 different effects of both integrins in this process.
Figure 5 Itga11 knockdown decreased mRNA and protein amount. A. Relative quantities of Itga4 (soft grey) and Itga11 (white) mRNA for
treated cultures, or untreated cultures (black) in MSC. For treated cultures with negative control shRNA (dark grey), both Itga11 and Itga4 mRNA
were quantified but to simplify, only the relative quantity of Itga11 is shown. B. Detection of ITGA11 by western blot during myogenesis. Proteins
were extracted from MSC culture, before (0 h) and during differentiation (24 h, 48 h and 72 h) and the quantities of ITGA11 were revealed by
western blot using Actin as control.
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We observed a large up-regulation of Chst5 during the
differentiation of MSC. So we treated MSC cultures
with shRNA against Chst5 and controlled the induced
repression by RT-PCR (Figure 9A). We also controlled
the correlation with the protein amount by western blot
in MSC (Figure 9B). The treated cultures showed a de-
crease of Chst5 expression and a lower protein amount.
After 24 hours in the differentiation condition, the fu-
sion index observed in culture treated with shRNA
against Chst5 was significantly lower than that observed
for the untreated culture (Figures 10 and 11). This
difference remains until 72 hours of differentiation but
appeared to decrease. This indicates that Chst5 inhibition
only induced a delay in MSC fusion. This result and those
obtained for Itga11 strengthen our gene selection.
Discussion
Cell migration, adhesion and fusion require many changes
in the cell surface and environment during myogenesis.
Janot et al. (2009) used a RT-PCR-based screening method
to detect 37 glycosylation related genes (GRG) with a large
variation in expression during the early myogenic dif-
ferentiation of C2C12 [15]. However, the genes specif-
ically involved in myogenesis were not distinguished
from those that were expressed independently from a
differentiation pathway and those which were associ-
ated with C2C12 immortality. In this study we refined
the screening using murine satellite cells (MSC) since(i) they better reflected the in vivo state and (ii) they
can be differentiated into myotubes or into early fat
storage cells. By comparing 383 GRG (Additional file 4)
expression in MSC differentiated in one or the other
differentiation pathway we retained 67 genes specific-
ally associated with the myogenesis out of 383 studied.
Compared to GRG previously found by Janot et al.,
these 67 genes can be divided into two groups. The first
one contains 17 genes whose expression varies in only
MSC. The second is composed of 50 genes with vari-
ation in both C2C12 and MSC, 14 only showing the
same pattern of expression. We did not retain the 36
other genes because differences in their expression pro-
files seemed to depend on cell type rather than on myo-
genesis. The discrepancy between these results and the
ones previously published by Janot and co-workers is
mainly due to a more drastic screening that discards
genes common to pre-adipogenic and myogenic differ-
entiation. So, we retained 31 genes that seem specifically
involved in myogenic differentiation.
We strengthened our selection by using “without a
priori” clustering of GRG selected in the MSC model.
We found 26 of the previously selected 31 genes were
distributed into 5 clusters among the 13 clusters ob-
tained. Cluster 5 included all 8 down-regulated genes. 6
of them had a similar variation during C2C12 and MSC
myogenesis (Table 1, group A). Since the other 23 genes
were all up-regulated in C2C12 and/or MSC, they were
mainly found in 4 clusters: clusters 3 and 7 which
Figure 6 Itga11 knockdown reduced myotube formation. Myogenic differentiation of MSC: untreated (Without), treated with plasmid
containing shRNA without target in murine genome (shRNA NEG), treated with plasmid containing shRNA for Itga4 (shRNA Itga4) or plasmid
containing shRNA for Itga11 (shRNA Itga11). Photos were taken at different time points after hematoxylin/eosin staining. Magnification was 400×
(for lower magnification see Additional file 3). Red arrows point myotubes.
Figure 7 Itga11 knockdown decreased fusion index. Fusion index of MSC cultures seeded at 5×103 cells/cm2 on Matrigel®. Cultures were
compared every 24 h after myogenic differentiation induction by serum starvation. Cultures were untreated (black), treated with plasmid
containing negative control shRNA (dark grey), treated with plasmid containing shRNA for Itga4 (light grey) or for Itga11 (white), see Methods.
Standard errors were calculated using triplicate and the Student t-test determined significant differences between control and treated cultures.
***p < 0.1%.
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Figure 8 Anti-ITGA4 and/or anti-ITGA11 antibodies inhibited cell fusion of myoblasts. A. Experiments were performed on cultures plated
on Matrigel® and under differentiation conditions. The five cultures were, untreated (triangles), treated with 1 μg/ml isotypic antibodies as negative
control (cross over squares), treated with 1 μg/ml anti-ITGA4 antibodies as positive control (squares), treated with 1 μg/ml anti-ITGA11
antibodies (circles) or treated with 0.5 μg/ml anti-ITGA4 and 0.5 μg/ml anti-ITGA11 antibodies (diamonds). Significance was calculated using
the t-test on three simultaneous replicates (see standard bars). ***indicates time with significant difference between WT and all neutralization tests,
p <0.1%. B. The specificity of anti-ITGA4 and anti-ITGA11 was controlled by western blot using 50 μg of cellular lysate. MW indicates the
molecular weight ladder.
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(4) and 8(6) which contain 11 group B genes and 2
group A genes. This demonstrates that our separation
and the distribution by “without a priori” clustering of
the GRG were very close.Figure 9 Chst5 knock-down decreased mRNA and protein amount. A.
untreated cultures (black) in MSC and for treated cultures with negative co
B. Western blot detection of CHST5 during myogenesis. Proteins were extr
(24 h, 48 h and 72 h) and the relative quantities of Chst5 were revealed byTo explore the relationship between GRG up- and
down-regulation, and myogenesis, we classified them
according to the function of their products (Table 2). Our
first observation was for Art1, one of the most up-
regulated genes, it encodes a mono-ADP-ribosyltranferaseRelative quantities of Chst5 mRNA for treated cultures (white), or
ntrol shRNA (dark grey), Chst5 mRNA were quantified by RT-PCR.
acted from MSC culture, before (0 h) and during differentiation
western blot using Actin as control.
Figure 10 Chst5 knockdown induced a late in myotube formation. Myogenic differentiation of MSC: untreated (Without), treated with
plasmid containing shRNA without target in murine genome (shRNA NEG), treated with plasmid containing shRNA for Chst5 (shRNA Chst5).
Photos were taken at different time points after hematoxylin/eosin staining. Magnification was 400x (for lower magnification see Additional file 3).
Red arrows point nucleus into myotubes.
Figure 11 Chst5 knockdown delayed the cell fusion. Fusion
index of MSC cultures seeded at 5×103 cells/cm2 on Matrigel®.
Cultures were compared every 24 h after myogenic differentiation
induction by serum starvation. Cultures were untreated (black),
treated with plasmid contains negative control shRNA (dark grey),
treated with plasmid containing shRNA for Chst5 (white), see Methods.
Standard errors were calculated using triplicate and the Student t-test
determined significant differences between control and treated
cultures. **p < 1%; *p < 5%.
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genes encoded proteins, which are involved in glycan
synthesis or modifications such as sulfation (e.g.: Chst5) or
hydrolysis (e.g.: Hpse). Most of them are responsible for
extracellular matrix synthesis (B4Galt1, Chst5, Chst12,
Cmah, Galntl1, Gcnt2, Has1 and Has2); they are up-
regulated while those coding for sulfation of glycans car-
ried by glycolipids or glycoproteins are down-regulated
(Chst8 and Chst10). The alignment of cells and myotubes
requires a different structural organization of the extra-
cellular matrix molecules such as lumican, composed
of keratan sulfates [53]. In this study, an up-regulation
of B4Galt1 and Chst5 involved in keratan sulfate bio-
synthesis was observed. The latter also depends on the
synthesis of O-glycan core 2 structure. 2 up-regulated
genes encoding proteins of the O-glycan biosynthesis
pathway, Galntl1 and Gcnt2, are also implicated. In
addition, considering all up- or down-regulated GRG
during myogenic differentiation, without taking into
account their variation in early adipogenesis, we found
that GRG expression variations were more favourable
for core 2 biosynthesis (Additional file 5). Indeed, Gcnt1
was up-regulated in both differentiation pathways. How-
ever, in myogenic cells, biosynthesis continued to keratan
sulfate since B4Galt1 and Chst5 gene expression in-
creased. So, we propose that the regulation of some
GRG contributes to core 2 O-glycan biosynthesis and
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myotube arrangements. Finally, it has been shown
recently that Gcnt1 up-regulation is associated with
myocardial hypertrophy in mice [54], which supports
our theory.
Significant adhesion protein involvement during cell fu-
sion is likely since 12 of the 31 genes encode proteins of
this family. Among them, we observed an up-regulation
of a protein containing a lectin domain, CLEC2D, a
murine osteoclast inhibitory lectin [25] necessary to
promote MSC myogenesis. The LGALS7 lectin plays a
key role in stabilization of glycoconjugates in epithelial
repair [31]. It could play a similar stabilizing role in
myogenesis. The up-regulation found for CD248 or
Endosialin, known as a potential actor of angiogenesis
in which it contributes to cell-cell alignment and con-
tacts [24], seems to be explained. Again, up-regulation
of KLRA2 (or Ly-49), a cell surface receptor of class 1
myosin heavy chain, could be related to the high expres-
sion of its ligand in skeletal muscle [30].
We also found into adhesion proteins 5 integrin sub-
units (ITGA5, ITGA6, ITGA11, ITGB7 and ITGB8) and
2 adhesion molecules (ICAM2 and MCAM). ICAM2,
whose expression increases during C2C12 and MSC
myogenesis, is notably expressed in adult satellite cells
[55]. It can link α-actin/actin to form a membrane-actin
interaction that reinforces cell-cell interactions as de-
scribed in neuroblastomas [26]. MCAM is known to
have a role in cellular adhesion and in cohesion of the
endothelial monolayer [32]; it could have the same role
in myogenesis. Moreover, Cerletti et al. reported that
Mcam gene is highly expressed in human foetal myo-
genic cells [56]. Therefore, there is a good relationship
between this result and the up-regulation found in MSC.
The integrin family is of particular interest and is often
involved in cell contact, signaling, adhesion and fusion
[19]. From our results, a network model (Figure 12),
with a central role for the integrins, is proposed to par-
tially explain myogenesis regulation. The Itga5 gene en-
coding an integrin subunit (ITGA5) was up-regulated.
ITGA5 forms a heterodimeric complex with ITGB1 and
then with Nischarin during control of cell migration [57].
Interestingly we observed that Hpse was also up-regulated.
The protein encoded by this gene (Heparanase) is known
for its role in cell migration through the digestion of
ECM, creating a balance with ITGA5 activity [41]. We
noticed the up-regulation of Itgb8. The ITGB8 protein,
associated with ITGAV and a metalloprotease, activates
transforming growth factor β-1 (TGF-β1) in epithelial
cells or neurons [27,28]. Although TGF-β1 is known to
inhibit myogenic differentiation [58], Gouttenoire et al.
demonstrated that it can also activate Itga11 transcrip-
tion in mouse chondrocytes [59]. In addition, genes
encoding hyaluronan synthases HAS1 and HAS2 areup-regulated and hyaluronans are described to promote
sequestration of the TGF-β1 receptor in lipid rafts
which limits their interaction with TGF-β1 [60]. Finally,
up-regulation of Chst12 involved in dermatan sulfate
biosynthesis may indicate an increase in the production
of decorin, known to bind and regulate the sensitivity of
chicken satellite cells to TGF-β1 [61]. All results suggest
that cells could regulate TGF-β1 effects through different
pathways and may limit its action to Itga11 activation
(described later). Our model also used cell signalling
according to the up-regulated integrin subunit ITGA6.
It forms a complex with ITGB1which has recently been
described as essential for neuronal differentiation of
human embryonic stem cells. The binding of the com-
plex to laminin molecules induced differentiation [29]
so we integrated a similar system in our model of myo-
genesis. Recently, ITGA6 was linked to the expression
of cell migration-related genes [62], it could be also
play a role in cell migration as ITGA5.
Laminin can also bind α-Dystroglycan and organize
muscle structure. The 120 kDa form of α-Dystroglycan,
in chicken myoblast cultures, is present at the late stage
of myogenesis [63]. This form is likely to be less rich in
mannose type O-glycan. In our model, we associated the
decrease in Pmm1 and Chst10 expression with this
phenomenon. Because PMM1 is involved in UDP-
mannose synthesis and the sulfotransferase, CHST10,
is responsible for terminal sulfation of O-mannosyl gly-
cans, they are presumably involved in cell adhesion
[64] and could be related to the structures present on
the α-Dystroglycan molecule [65].
Earlier, we showed that Itga11 showed the highest
variation in expression. This gene encoding the ITGA11
subunit has also been shown to be up-regulated during
myofibroblast differentiation in cardiomyopathy [66].
We included this integrin in our model because it has
already been described to be produced by human cor-
neal myoblasts and to be involved in development of
the latter [67]. To verify the involvement of selected
GRG in myogenesis, Itga11 and Chst5 were chosen for
a functional study. Treatment of MSC with shRNA di-
rected against the Itga11 transcript before and during
myogenic differentiation strongly inhibited cell fusion.
ITGA11 depletion stopped the fusion after 24 hours
only (Figure 8). The MRFs expressions were followed
during the differentiation of treated cells and we ob-
served a complete inhibition of the Myf6 expression
(Additional file 6A). The expression of Myf6 is usually
related to the fusion process. The addition of anti-ITGA11
antibodies strongly inhibited fusion; after 72 hours, under
differentiation conditions, less than 7% fusion was ob-
served. The same result was obtained with anti-ITGA4
antibodies and ITGA4 is known for its involvement in
fusion during myogenesis [52]. The combined action of
Figure 12 Interaction network leading to cell fusion during myogenesis. The network was constructed according to the literature and
based on twelve variant genes. Genes are in bold (+: up-regulated or −: down-regulated). The thickness of the lines is proportional to the expression
levels of genes during myogenesis. Blue arrows show the pathways checked by functional experiments. Myogenic steps are in purple rectangles and
boxed in red when cells are engaged in this step and in white for later steps.
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cell fusion. This result demonstrated that the effect of
each antibody could be cumulative (or synergistic).
Since no compensations were observed in shRNA ex-
periments, we suggest that the two integrins contrib-
ute independently to the binding of cells to different
MEC components. Now it is clear that ITGA11 plays a
role during myogenesis, especially in the fusion process.
The cells treated with shRNA against Chst5 showed a
delay in fusion during the first 48 hours of differentiation.
However, they recovered a fusion index quietly similar
to untreated cells at 72 hours under differentiation con-
ditions. This effect could be explained by the involve-
ment of CHST5 in the sulfation of keratans. The low
amount of CHST5 during 48 hours of differentiation
was not sufficient to permit enough sulfation of kera-
tans and thus the cell fusion. Beyond of the 48 hours,
the keratan sulfate amount was sufficient to allow a
quick fusion of cells. Indeed, at 72 hours of differenti-
ation the fusion index was close between treated and
untreated cultures. This result correlated to the MRFs
expression observed during the differentiation of treated
cells (Additional file 6B). Indeed, MyoG up-regulation
during the first 24 hours showed that cells are engaged in
myogenesis. The Myf6 expression increased only from48 hours and harshly rose until 72 hours as observed for
the fusion index. These results demonstrate the import-
ance of Chst5 to initiate the fusion step of myogenesis.
The relationship between Itga11, Chst5 and myogenesis
step strengthens our selection as well as our myogenic
regulation model.
Conclusion
In this study, the comparison between the adipogenic
and myogenic differentiation of MSCs, as well as be-
tween two cell types (C2C12 and MSC) that differenti-
ate into myotubes allowed us to select 31 genes whose
expression is particularly associated with myogenesis.
We classified these genes into 3 groups, according to
the function of the proteins they encode: (i) remodel-
ling of the extracellular matrix where genes are pre-
dominantly up-regulated such as Chst5; (ii) glycan
biosynthesis with more particularly an up-regulation of
genes involved in core 2 glycan synthesis; (iii) adhesion
where genes are mainly up-regulated such as Itga11. We
have also shown that Itga11 knockdown and neutralization
of ITGA11 protein strongly inhibit cell fusion whereas the
knockdown of Chst5 delayed the fusion of myoblast.
These results emphasize our selection of genes and their
involvement in myogenesis. We suggest a potential
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GRGs are strongly implicated. Finally, this study pro-
vides a suitable complementary method for the study
of specific differentiation pathways.
Methods
Cell cultures
The murine C2C12 myoblast cell line (ATCC, Manassas,
VA, USA) was cultured in DMEM (Dulbecco’s modified
Eagle’s medium, Eurobio, Courtaboeuf, France) supple-
mented with L-Glutamin, 10% (v/v) fetal calf serum
(Eurobio), 50 units/mL penicillin and 50 μg/ml strepto-
mycin. Cells were grown to 80% confluence and differ-
entiated into myotubes in DMEM supplemented with
5% (v/v) horse serum (Invitrogen, Carlsbad, CA, USA).
The medium was changed every 48 hours.
Murine satellite cells were extracted from posterior
leg muscles of C3H mice as previously described [68].
Cells were cultured in “medium A” containing HAM
F10 medium (Sigma) supplemented with 5 mM L-glu-
tamin, 20% (v/v) horse serum, 50 units/mL penicillin,
50 μg/mL streptomycin and 5 ng/mL Basic-Fibroblast
Growth Factor (Sigma). At 70% confluence cells were
differentiated into myotubes with HAM F10 medium
supplemented with 10% (v/v) horse serum or trans-
differentiated into fat storage cells when 50 mM glu-
cose were added to “medium A”.
Determination of cell fusion index and staining of early
fat storage cells
After removing culture medium, cells were washed twice
with PBS, fixed with 10% (v/v) formalin for 15 min at
room temperature and washed twice again with PBS.
Nuclei were stained with Shandon Harris hematoxylin
(0.44% (v/v), Thermoscientific, Courtaboeuf, France) for
1 hour at room temperature and then washed twice with
PBS. Cytoplasm was stained with Shandon eosin Y aque-
ous (0.5% (v/v), Thermoscientific) for 30 min at room
temperature. Fusion index of C2C12 and satellite cells
was determined by the ratio between nuclei in myotubes
and total nuclei on six different microscopic fields.
To identify early fat storage cells, fixed cells (10% (v/v)
formalin, 30 min, 37°C) were stained with 0.3% Oil-Red-
O (Sigma) in 60% isopropanol according to the protocol
described by Salehzada et al. [69].
Quantitative real-time PCR (QRT-PCR)
For each kinetic point, cells were rinsed twice with PBS
and harvested following trypsinization (PBS, 1 mM EDTA,
0.05% (w/v) trypsin). Total RNA was extracted using the
RNeasy mini Kit (Qiagen Inc., Hilden, Germany). A micro-
fluidic chip was used to measure quality and quantity of
total RNA (Agilent 2100 Bioanalyser, Agilent Technologies
Inc., Santa Clara, CA, USA) and 1 μg was converted intocDNA using the High Capacity cDNA Archive Kit
(Applied Biosystems, Foster city, CA, USA).
mRNA was quantified by QRT-PCR on ABI Prism 7900
Sequence Detector System using TaqMan probe-based
chemistry (Applied Biosystems), with 6-carboxyfluorescein
(FAM) as a reporter. cDNA (2 ng) was used to quantify
myogenic and adipogenic markers and target genes in
96-well plates and Taqman Low Density Array (TLDA)
respectively. In addition to genes already present on
TLDA as previously described by Janot et al. [15], we
also followed the expression of 8 genes encoding integ-
rin subunits (Itga1, Itga8, Itga10, ItgaD, ItgaE, ItgaV,
Itgb1, and Itgb6) to complete this gene family. Relative
quantification was performed using five reference genes:
18S RNA, G6pdx, Gapdh, Tcea, Tbp.
Data analysis and clustering
mRNA gene transcription data were collected and ana-
lyzed using SDS 2.2.2 software (Applied Biosystems). The
first accessible data was the Ct, the minimum number of
cycles necessary to obtain a significant fluorescent signal;
therefore genes with a Ct above 35 were considered as not
expressed. Relative quantification was obtained using the
ΔΔCt method [15]. mRNA quantity was normalized using
Cts from Gapdh, Tbp and 18S RNA and t = 0 h was used
as a reference sample. The evolution of the expression
level along the kinetic points was also considered to
discard point showed aberrant relative quantity (e.g.
RQ = 0.001 or RQ = 10000). The relative quantity for
these points was indicated as “not determined” (n.d.).
The following process for distance computation as well
as hierarchical clustering was performed with a script, per-
sonally communicated by G. Lelandais and previously
used by Lucau-Danila et al. [70]. All genes for which a
change of more than two folds was observed at least once
during the experiments were selected using Log2 (ratio)
data sets of time courses. A cluster analysis was conducted
on similarity measurements between the differential gene
expression profiles. More precisely, each gene can be given
a coordinate of two expression vectors defined as C2C12g
(Tm) and SatCg(Tm), where C2C12g(Tm) and SatCg(Tm)
are the logarithms to base 2 of the ratios for gene g in
C2C12 or satellite cells respectively, measured at Tm, the
time point of the kinetic [Tm which is included in T (12 h,
24 h, 48 h, 72 h)]. Thus, considering two genes, g1 and g2,
the similarity (D) between them is computed as follows:




C2C12g1 Tmð Þ ‐ C2C12g2 Tmð Þ
 2 þ SatCg1 Tmð Þ − SatCg2 Tmð Þ
 2q
A complete-linkage hierarchical clustering analysis was
performed next, by using the distance matrix. Initially,
each object is assigned to its own cluster and then, at
each stage, the two most similar clusters are joined by
the algorithms that proceed iteratively. The process
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resulting tree is finally split into several groups of genes.
Library function in R was used [http://cran.r-project.
org], and graphical representations were obtained with
MeV (MultiExperiment Viewer v 4.7.4) [71].
Immuno-neutralization experiments
One day before induction of differentiation, satellite cells
were treated with 1 μg/mL isotypic antibodies (purified
sheep IgG, R&D systems), rat anti-ITGA4 or sheep anti-
ITGA11 (R&D systems, Minneapolis, MN, USA). Treat-
ments with anti-ITGA4 or isotypic antibodies were used
as positive or negative controls respectively. Immuno-
neutralization was maintained by addition of antibodies
every 24 hours at the same concentration. For these kin-
etic points, the fusion percentage was determined using
culture without antibody as assay.
Knockdown by ShRNA
MSC were seeded at 5×103 cells/cm2 on Matrigel®-
coated plates, cultured in growth medium for 2 days
and cultured in differentiation medium for 3 days. The
medium was changed every 24 hours and cells were
treated during the days 2 and 3. Treatments were
200 μL medium containing 4 μg plasmid and 2 μL
transfecting reagent (Attracten, Qiagen). Cells were
untreated, treated with a plasmid containing shRNA
without target, treated with plasmid containing shRNA
targeting Itga4 or treated with plasmid containing
shRNA targeting Itga11 or Chst5. Cultures were stopped
and stained every 24 hours during differentiation and
the fusion percentage was calculated. Total RNA was
also collected and knock-down of Itga4, Itga11 and
Chst5 expression was verified by PCR with Gapdh as





GTGC and Chst5-Reverse: TCAAGGAGGTGCGCTT
CTTT. The relative quantity was determined as follows:
(i) the area and mean grey values were taken into ac-
count, (ii) obtained values were normalized to Gapdh
(iii) normalized values for the control culture were
assigned a value of 1 for each time point (iv) final ratios
were equal to normalized values obtained for treated
cultures at a certain time points divided by values for
untreated cultures at the same times.
Western blot analysis
At each time point of differentiation, cell proteins were ex-
tracted with Triton buffer (Tris 50 mM Tris, 0.5% (v/v)
Triton X-100, 0.5% (w/v) sodium deoxycholate, pH7.4,
protease inhibitor cocktail (Roche, Boulogne-Billancourt,France)). Proteins (50 or 100 μg protein loaded per lane)
were resolved by SDS-PAGE using 10%-polyacrylamide
gels. Proteins were transferred to nitrocellulose membrane
for 90 minutes at 0.8 mA/cm2. Membranes were saturated
with TBS (20 mM Tris,137 mM NaCl, pH7.6) supple-
mented with 0.1% (v/v) Tween 20 and 2.5% (w/v) pow-
dered skim milk, for 1 h 30 at room temperature. Blots
were probed with anti-ITGA11 (1 μg/mL at 4°C over-
night, R&D systems) or anti-CHST5 antibodies (1 μg/mL
at 4°C over-night, Bios) followed by peroxidase coupled
goat anti-rat IgG for ITGA11 (1:1000 for 1 h 30 min at
room temperature, R&D systems) or by peroxidase
coupled swine anti-rabbit IgG for CHST5 (1:1000 for
1 h 30 min at room temperature, Dako). Bands were visual-
ized by enhanced chemoluminescence (CN 11500694001,
Roche). Membranes were washed 3 times with TBS-0.05%
(v/v) Tween after incubations.
Availability of supporting data
The data set supporting the results of this article is in-
cluded within the article (Additional file 7).
Additional files
Additional file 1: Satellite cells differentiate into myotubes or early fat
storage cells. A, B. Satellite cells at t = 72 h under myogenic differentiation
conditions, plated on Matrigel®, without (A) or with (B) hematoxylin/eosin
staining. Magnification 100×. Arrows point myotubes. C, D. Satellite cells
under early adipogenesis trans-differentiation conditions, plated on Matrigel®,
at differentiation time t = 168 h. (C) before and (D) after staining with
Oil-Red S. The black arrows show lipid accumulation in cells and red arrow
shows the nucleus. Magnification 400×.
Additional file 2: Sixty-seven genes regulated only during myogenic
differentiation of MSC. List of up or down regulated genes during myogenic
but not adipogenic MSC differentiation and their expression variation.
Additional file 3: shRNA against Itga11 and Chst5 inhibit and delayed
fusion respectively. Myogenic differentiation of MSC: untreated (Without),
treated with plasmid containing shRNA for Itga11 (shRNA Itga11) or
shRNA for Chst5 (shRNA Chst5). Photos were taken at different time
points after hematoxylin/eosin staining. Magnification was 100×.
Additional file 4: Three hundred and eighty three genes under study.
List of the 383 genes selected from the murine glyco-genome and used
for our screening.
Additional file 5: Orientation of O-glycan biosynthesis. Mucine type
O-glycan biosynthetic pathway representation with its enzymes
(+: up-regulated, − : down-regulated, H: high constant expression, L: low
constant expression) during myogenic differentiation. Red lines symbolize
the activated synthetic pathways and the black lines the repressed ones.
Core and F1α correspond to the name of the glycan structures: (●) all
genes leading to this structure are expressed; (○) some genes in the
pathways have no or very low expression. Modified from KEGG Pathway
(http://www.genome.jp/kegg/pathway.html).
Additional file 6: MRFs expression during differentiation of shRNA-treated
cells. A.B. Expression of the MRFs (MyoG (circles), MyoD1 (squares), Myf5
(diamonds), Myf6 (triangles)) during the differentiation of satellite cells
treated with shRNA against Itga11 (A) or Chst5 (B).
Additional file 7: Data supporting this article. Excel table including all
TLDA results for C2C12 and satellite cells experiments.
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